the program

MEET 2015 Course Directors
Max Amor
Nicholas Cheshire
Eric Ducasse
Mario Lachat
Nicola Mangialardi
Peter Schneider
Isabelle Van Herzeele
Honorary Directors
Patrice Bergeron
Piergiorgio Cao
Luigi Inglese
Thomas Ischinger
Klaus Mathias
Dieter Raithel
june
8-9
2015
nice
Scientific Committee
Jérôme Brunet
Massimiliano di Primio
Roberto Ferraresi
Yann Gouëffic
Ian Loftus
Richard McWilliams
Sonia Ronchey
Founding Directors
Max Amor
Patrice Bergeron
france
FINAL PROGRAM
www.meetcongress.com
12 European
CME credits
Welcome to MEET 2015
congress synoptic
It is a great pleasure to welcome you on the French Riviera, in the beautiful city of Nice with its unique light, refined lifestyle
and multiple perfumes and flavors.
More videos, clinical cases, interactivity and audience discussions will ensure that MEET 2015 offers a multidisciplinary
educational platform.
Over the two-day congress, our wide-ranging, interactive program will include the whole range of endovascular techniques
and procedures and focus on femoropopliteal and BTK disease, the management of thoracic aortic dissection, EVAR
challenges and carotid artery stenosis. Do not miss the interesting work-in-progress and case reports presented by the
associate faculty members, including trainees, on Tuesday afternoon.
Nurses and technicians will have the opportunity to participate in an intensive, one-day, special program tailored for them in
a parallel room on Monday.
Take your time to visit the exhibition and discover the Industry news as it is only thanks to their precious help that we managed
to organize this congress.
Monday June 8
Main program
08.30
Opening remarks
08.35
BTK strategies and
best options
Again, welcome to the capital City of the French Riviera, we look forward to building endovascular synergies with you and
our outstanding international faculty.
10.00
Coffee break
10.30
BTK strategies and
best options
The MEET Directors
M. Amor, N. Cheshire, E. Ducasse, M. Lachat, N. Mangialardi, P. Schneider, I. Van Herzeele
Tips & tricks and
complications
11.20
Thoracic pathology
How I deal with the
aortic arch:
from planning to followup
2
COURSE DIRECTORS 2015
Max AMOR, Essey-les-Nancy, France
Nicholas CHESHIRE, London, United Kingdom
Eric DUCASSE, Bordeaux, France
Mario LACHAT, Zurich, Switzerland
Nicola MANGIALARDI, Rome, Italy
Peter SCHNEIDER, Honolulu, USA
Isabelle VAN HERZEELE, Gent, Belgium
HONORARY DIRECTORS
Patrice BERGERON, Marseille, France
Piergiorgio CAO, Rome, Italy
Luigi INGLESE, San Donato Milanese, Italy
Thomas ISCHINGER, Munich, Germany
Klaus MATHIAS, Hamburg, Germany
Dieter RAITHEL, Spardorf, Germany
SCIENTIFIC COMMITTEE
Jérôme BRUNET, Avignon, France
Massimiliano DI PRIMIO, Le Chesnay, France
Roberto FERRARESI, Milan, Italy
Yann GOUËFFIC, Nantes, France
Ian LOFTUS, London, United Kingdom
Richard MCWILLIAMS, Liverpool, United Kingdom
Sonia RONCHEY, Rome, Italy
FACULTY
Flavio AIROLDI, Milan, Italy
Max AMOR, Essey-Les-Nancy, France
Patrice BERGERON, Marseille, France
Jérôme BRUNET, Avignon, France
Jan BRUNKWALL, Köln, Germany
Jacques BUSQUET, Saint-Cloud, France
Nicholas John W. CHESHIRE, Londres, United Kingdom
Jason CONSTANTINOU, London, United Kingdom
Raphael COSCAS, Boulogne Billancourt, France
Jean-Paul DE VRIES, Nieuwegein, The Netherlands
Koen R. DELOOSE, Dendermonde, Belgium
Massimiliano DI PRIMIO, Le Chesnay, France
Eric DUCASSE, Bordeaux, France
Roberto FERRARESI, Bergamo, Italy
Mauro GARGIULO, Bologna, Italy
Yann GOUEFFIC, Nantes, France
Alison W. HALLIDAY, London, United Kingdom
Luigi INGLESE, San Donato Milanese, Italy
Elixène JEAN-BAPTISTE, Nice, France
Xiongjing JIANG, Beiking, China
Piotr KASPRZAK, Regensburg, Germany
Tilo KOLBEL, Hamburg, Germany
Ralf R. KOLVENBACH, Düsseldorf, Germany
Mario L. LACHAT, Zurich, Switzerland
Thomas LARZON, Orebro, Sweden
Ian LOFTUS, London, United Kingdom
Lieven MAENE, Aalst, Belgium
Nicola MANGIALARDI, Roma, Italy
Armando MANSILHA, Porto, Portugal
Klaus MATHIAS, Hamburg, Germany
Richard MCWILLIAMS, Liverpool, United Kingdom
Davide PACINI, Bologne, Italy
Andranik PETROSYAN, Bron, France
Raffaele PULLI, Firenze, Italy
Enrique PURAS MALLAGRAY, Madrid, Spain
Zoran RANCIC, Zurich, Switzerland
Vincent RIAMBAU, Barcelona, Spain
Sonia RONCHEY, Roma, Italy
Antoine SAUGUET, Toulouse, France
Thomas SCHMITZ RIXEN, Frankfurt/Main, Germany
Peter SCHNEIDER, Honolulu, USA
Francesco SETACCI, Rome, Italy
Carlo SETACCI, Siena, Italy
Kenneth SNYDER, Suite Buffalo, USA
Johnny STEUER, Uppsala, Sweden
Fabien THAVEAU, Strasbourg, France
Rao Srinivasa VALLABHANENI, Liverpool, United Kingdom
Jos VAN DEN BERG, Lugano, Switzerland
Isabelle VAN HERZEELE, Gent, Belgium
Frank J. VEITH, Riverdale, USA
Pierfrancesco VEROUX, Catania, Italy
Fabio VERZINI, Perugia, Italy
Session paramédicale
Main program
08.15
Carotid Occlusive Disease
10.00
Coffee break
State of the art of BTKCLI treatment
As usual the plenary sessions will be broadcast live on Internet. Do tell your colleagues at home.
Do not miss our privileged official dinner on Monday night on the Radisson Hotel’s beach privatized for us to share with you a
unique moment of conviviality.
Tuesday June 9
13.00
14.00
Café d’accueil
10.30
Carotid Occlusive Disease
Session
paramédicale
1
12.15
13.00
Rooftop lunch break
Thoracic pathology
Dissection
Descending aorta
15.45
Highly complex
lesions in femo/pop.
What do I learn from
my daily practice?
16.15
Coffee break
16.30
Femoropopliteal
disease
11.15
14.00
Moving toward Drug
Eluting Solutions
Rooftop lunch break
The A-Z of A-I disease
Access
Imaging
AAA
Session
paramédicale
2
Pause sur le hall d’exposition
et fin des sessions
Femoropopliteal disease
TASC C/D femoropopliteal lesions
Managing complications
16.00
Associate Faculty and Trainees
program
18.30
Awards ceremony & Adjournment
Strategy
TASC A/B
femoropopliteal lesions
18.21
End of the sessions
20.00
Official dinner
MEET is compliant with the Eucomed Code of Ethical Business Practice
CASE REPORTS AND
RECORDED VIDEO CASES
FREE WEBCAST OF THE
WHOLE CONGRESS
INTERACTIVE VOTING
www.meetcongress.com
3
Monday June 8
08.30Opening remarks
Course directors
14.00 Thoracic pathology
08.35
BTK strategies and best options
Dissection
Moderators: R. Ferraresi, A. Sauguet, E. Ducasse
State of the art of BTK-CLI treatment
08.35
Arterial status, angiosome, arterial calcifications, is it possible to plan treatment
at BTK level? M. Gargiulo
08.43
Big vessel versus small vessel disease: what is the true cause of critical limb ischemia?
R. Ferraresi
08.51
BTK long lesions: devices and optimal treatment, R. Ferraresi
08.59
Insight about ultrasound in planing, access and control of BTK angioplasty,
E. Puras Mallagray
09.07 BTK bifurcations: best treatment, F. Airoldi
09.15 Discussion
State of the art:
09.20
Drug eluting stent in BTK disease, K. Deloose
09.28
Bare metal stent in BTK disease, E. Ducasse
09.36 Drug eluting balloon in BTK disease, K. Deloose
09.44
Distal bypass in BTK disease, P. Schneider
09.52Discussion, M. Di Primio
10.00 Coffee break in the exhibition hall
4
www.meetcongress.com
Tips & tricks and complications
10.30 Challenging BTK case, E. Ducasse
10.40
When coronary devices could help? A. Sauguet
10.50
Below-the-ankle angioplasty and stenting for CLI, J. Brunet
11.00
Extreme distal revascularization with conventional and alternative techniques,
M. Di Primio
11.10 Discussion
11.20Thoracic pathology
Moderators: S. Ronchey, F. Veith, A. Bray
How I deal with the aortic arch:
from planning to follow-up
FREE WEBCAST OF THE
WHOLE CONGRESS
Moderators: J. Busquet, F. Veith, M. Lachat, N. Mangialardi
14.00 We do treat all - and why, N. Cheshire
14.08
I do treat when appropriate, J. Steuer
14.16
The false channel occlusion technique, T. Kölbel
14.24 TEVAR for chronic dissection, I. Loftus
14.32
News from imaging will change our attitude, L. Maene
14.40Discussion
Descending aorta
14.50
TEVAR European guidelines, V. Riambau
14.58
How I fix endoleak in TEVAR, P. Kasprzak
15.06
Clampless sutured anastomosis technique, Z. Rancic
15.14
Long-term results for TEVAR after BAI, R. Vallabhaneni
15.22
Access vessels challenges and best access route, F. Setacci
15.30
Discussion
15.45Highly complex lesions in femo/pop.
What do I learn from my daily practice?
15.45
Clinical case review, J. Brunet
15.57
Clinical case review, M. Amor
16.09
Discussion
16.15 Coffee break in the exhibition hall
16.45 Femoropopliteal disease - Part 1
Moderators: Y. Gouëffic, K. Deloose, P. Schneider, C. Setacci
Strategy
16.45 Anti-platelet therapy: who needs it and what to prescribe, K. Deloose
16.53 Popliteal artery aneurysm - What is the best mode of treatment? T. Schmitz Rixen
17.01 Radial access for femoropopliteal lesions: tips and tricks, R. Coscas
17.09 Closure devices: treatment of complications, J. Van den berg
17.18
Discussion
11.20
My experience in ascending aorta TEVAR, I. Loftus
11.28
Open surgery conventional: discrepancy in results (lights and shadow), D. Pacini
11.36
Ascending aorta: is the endovascular approach realistic? T. Kölbel
11.44
Off the shelf solution: selection based on planning, N. Mangialardi
11.52
My planning for arch Chimney, J. Brunkwall
12.00
Endoleak after arch Chimney, R. Kolvenbach
12.08
Hybrid repair: technique for total debranching, P. Bergeron, A. Petrosyan
12.16
Stroke rate and mortality in arch procedures, M. Lachat
12.24
Endovascular arch repair following ascending aorta open surgery, T. Kölbel
12.32
Complications of supraaortic debranching, S. Ronchey
12.40
Demonstration (crazy arch case), T. Larzon
12.48Discussion
TASC A/B femoropopliteal lesions
13.00 Buffet lunch served on the rooftop, coffee served in the exhibition hall
18.21 End of the sessions
20.00 Official dinner (page 7)
17.20Is connected stent the good option for TASC A/B SFA lesions? E. Ducasse
17.30Discussion
Debate. TASC A/B femoropopliteal lesions treatment
17.35 Stent should be the first line treatment, J-P. de Vries
17.43 Two-year results of a low-dose drug-coated balloon for revascularization of the
femoropopliteal artery (ILLUMENATE FIH Trial), Y. Gouëffic
17.51 DES should be the first line treatment, J. Van Den Berg
17.59 Discussion
18.05 Are current stents ready for the « surgical landing-zones »? L. Maene
18.13
Lecture from China: Selective stent placement versus balloon angioplasty for
renovascular hypertension caused by Takayasu Arteritis: two-year results, X. Jiang
5
Tuesday June 9
08.15
Carotid Occlusive Disease - Are we ready for the next breakthrough?
12.15Moving toward Drug Eluting Solutions
08.15
State-of-the-art: promising next steps, K. Mathias
08.30What the data is telling us: the first 30 days need to be safer after any carotid repair,
but how? C. Setacci
08.38 New stent designs: will they improve results? P. Schneider
08.46 New access technologies, N. Cheshire
Controversy
08.54Best medical therapy has improved: but how much, and will BMT be good
enough to replace repair? I. Van Herzeele
08.59Carotid endarterectomy remains the treatment of choice. The data proves it
and stents cannot compete, A. Mansilha
09.04 Discussion
09.09What is the optimal approach to asymptomatic carotid stenosis? Intervention or not?
We cannot all be correct!, A. Halliday
09.17Challenging case: the worst complication of the year. Can you help me problem
solve? M. Amor
09.25 Emergency management system: how to handle evolving stroke, K. Mathias
09.33 Selection of stent and protection technique: which stent for which lesion, M. Amor
09.41 Mechanical thrombectomy for acute stroke, K. Snyder
09.52Discussion
12.15
Clinical results Majestic trial, K. Keirse
12.35
Experience of drug eluting technologies, M. Sibé
Moderators: M. Amor, P. Schneider, K. Snyder, L. Inglese
10.00 Coffee break in the exhibition hall
6
www.meetcongress.com
10.30
Results from the ROADSTER Trial and EU Experience, I. Van Herzeele
10.38 CAS revival is now, P. Bergeron
10.46 Get organized for in hospital stroke (jatrogenic or not) acute rescue, L. Inglese
10.54Discussion
11.00 How I see the future of CAS, F. Veith
11.15Femoropopliteal disease - Part 2
Moderators: Y. Gouëffic, K. Deloose, P. Schneider, C. Setacci
TASC C/D femoropopliteal lesions
11.15
Heparin bounded graft could challenge endovascular repair for TASC C-D lesions?
R. Pulli
11.23Intra versus subintimal routes to treat femoropopliteal CTO lesions: techniques and
results, F. Thaveau
11.31 Endovascular treatment of occluded popliteal artery aneurysm, P. Veroux
11.39Discussion
Managing complications
11.45How should we manage acute in-stent thrombosis during femoropopliteal
recanalization? Y. Gouëffic
11.53 Recurring in-stent restenosis: what is the best management? E. Ducasse
12.01 Acute popliteal endograft occlusion: frequency and management, E. Puras Mallagray
12.09 Panel discussion
FREE WEBCAST OF THE
WHOLE CONGRESS
Moderator: M. Amor
13.00 Buffet lunch served on the rooftop, coffee served in the exhibition hall
14.00
The A-Z of A-I disease
Moderators: R. McWilliams, I. Van Herzeele
Access
14.00How I do PEVAR? – Video, Z. Rancic
Imaging
14.08Overlay and dose reduction during aortic procedures, J. Constantinou
AAA
14.16Will EVAS replace EVAR? I. Loftus
14.24EVAS and EVAR: What are the differences in case selection, deployment and
surveillance? F. Torella
14.32 Single sided access for EVAR: the future, M. Lachat
14.40 Review of the literature on type II endoleaks, R. McWilliams
14.48 Late endoleak management – case discussions – MCQ’s, J. Van Den Berg
14.56 State of the art – How I do FEVAR? P. Kasprzak
15.04 Troubleshooting after FEVAR, R. Vallabhaneni
15.12Iliac branched devices versus Iliac branched endoprothesis – differences in selection
and usage, F. Verzini
15.20 The lessons I have learned from RCT on RAAA management, F. Veith
15.28 New evidences for hypogastric artery preservation during EVAR, E. Jean-Baptiste
15.36 Tips and tricks for the CERAB technique, K. Deloose
15.44 Is the endovascular world ready for 3D-printing and... vice versa? L. Maene
15.50Discussion
16.00Associate Faculty and trainees program
From start to excellency
Jury: N. Cheshire, P. Bergeron
Oral presentations in the auditorium, listed on page 8
Jury: N. Mangialardi, E. Ducasse
ePosters presentations in the exhibition hall, listed on page 9
18.30 Awards ceremony & adjournment
MEET Official dinner
Radisson BLU Hotel
Monday June 8 - 20.00 till midnight
Limited seats
Participation fee:
60 € VAT incl. per person (buffet dinner)
Music Entertainment
Dress code: casual chic
7
Oral presentations
ePosters
• Long-term performance of closed cell design self-expanding stainless steel stents in the treatment
of Cockett’s Syndrome, Luis Loureiro
•C
arotid artery stenting with cerebral embolic protection: a single-center initial experience,
Pablo Nuñez
• Loss of kidney function after endovascular treatment of peripheral arterial disease, Lars Bolt
•M
icrocoil embolization for an acute bleed from ruptured middle rectal artery aneurysm,
Vivek Vohra
• Novel innovative endovascular technique to salvage acute limb ischemia in Hostile Groin,
Virendersingh Sheorain
• Management of long flush superficial femoral artery occlusions with ipsilateral antegrade common
femoral artery access, Amr Aborahma
• Percutaneous imaging guided techniques of PV patency and integrity management - catheter
directed local thrombolysis, stenting, endoluminal RFA & angioplasty or endoluminal RFA & stenting,
Malkhaz Mizandari
• Neurocognitive functioning after carotid endarterectomy and carotid stenting with filter protection
or flow reversal, Maarten Plessers
• Mid-term outcome of hybrid revascularisation procedures for TASC C and D aorto-iliac and femoropopliteal disease, Vassilios Zymvragoudakis
•A
therosclerotic plaque analysis in the lower limb may help predict outcome following
endovascular intervention, Vassilios Zymvragoudakis
•U
se of drug-coated balloon angioplasty as first line treatment for all femoropopliteal lesions: twelve
month results, Koen Keirse
•P
ercutaneus exclusion of subclavian artery aneurysm with endoprosthesis, Cinzia Moncalvo
•R
evascularization of the plantar arch: its impact on foot salvage in critical limb ischemia,
Mosaad Soliman
• Interventional treatment of an intracranial left vertebral artery stenosis in the state of contralateral
vertebral artery occlusion, Svetlin Tsonev
• Percutaneous exclusion of renal artery aneurysm with endoprosthesis, Cinzia Moncalvo
• What is the best solution for in-stent restenosis after SFA stenting: redo-PTA by use of POBA, drugcoated balloons or stent-grafts, Koen Keirse
• Adjunctive procedures to lower risks of neurovascular complications in thoracic endovascular
aortic repair: experience in the Oxford Regional Vascular Unit, Francesca Fratesi
• Thrombosis of femoral-popliteal graft treated with ultrasound assisted catheter – directed
thrombolysis and stenting, Cinzia Moncalvo
8
• Abdominal aortic aneurysm repair increases cardiovascular risk, Vimal Gokani
• Does reintervention influence the late results of EVAR? Diletta Loschi
• Early outcomes of patients transferred with ruptured suprarenal aneurysm or dissection: implications
for the organisation of vascular services, Nung Rudarakanchana
• The Re-entry catheter system for subintimal recanalization of chronic total occlusions in
femoropopliteal arteries: primary safety and efficacy results of the Re-ROUTE trial, Koen Keirse
• Percutaneous recanalization of occluded renal arteries in patient with resistant hypertension and
high rennin activity, Ivo Petrov
• Vertebral stenting, Iveta Tasheva
• Intervention for acute lower limb ischemia: a 3 year single center experience, Keisuke Fukuda
Notes
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
• Wich stent graft system can be used for challenging anatomy in EVAR cases, Koen Keirse
................................................................................
• Three cases confirming the appropriateness of “centralization of flow concept” in aortic dissection,
Ivo Petrov
................................................................................
• Artificial intelligence algorithms to quantify arterial calcification, Ahmed Aber
• Carotid Artery Stenting: is it possible to reduce complications? Cinzia Moncalvo
• Endovascular repair of mycotic thoracic aneurysm, Baris Ozdemir
• Is there a place for a prosthesis in the treatment of aortic graft infection? Sebastien Deglise
• Overcoming difficult CTO increasing the applicability of endovascular intervention to patients with
challenging Re-entry, Ahmed Tawfik
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
LIVE CONFERENCES ON www.meetcongress.com
Rewatch online for free the authorized presentations after the congress
................................................................................
................................................................................
9
Lundi 8 juin 2015
General information
LE PIOL
Session paramédicale
Nice Train
Station
GAMBETTA
LA MADELEINE
Av
.d
el
aB
or
na
la
L’ARCHET
Bd Carlone
Voie
M
athis
Av. Fleurs
Rue Bottero
go
ic
Bd V
u
tor H
Mercure Nice
Centre Grimaldi
10 min by bus
nte
a
Rue D
a
el
é
er t
Lib
d
ue
sP
os
te
tel
’Hô
el
ed
Ru
elli
tor
de
THIERS
s
Pa
e
Ru
JEAN-MÉDECIN
s
ongré
FACULTÉ
Max Amor, Radiologue Interventionnel, Clinique Louis Pasteur, Essey-Les-Nancy
Michaela Dupont, Manipulatrice en Electro Radiologie Médicale, CHU Bordeaux
Marie Etlinger, Directrice Marketing, Boston Scientific
Fabienne Lamniai, Manipulatrice en Electro Radiologie Médicale, CH Nantes
Karine Malo, Infirmière IBODE, CHU Bordeaux
Sophie Pichon, Manipulatrice en Electro Radiologie Médicale, CH Nantes
Julien Poor, Manipulateur en Electro Radiologie Médicale, Clinique Louis Pasteur, Essey-Les-Nancy
Florian Robert, Manipulateur en Electro Radiologie Médicale, Clinique Louis Pasteur, Essey-Les-Nancy
Robert Valette, Manipulateur en Electro Radiologie Médicale, La Timone, Marseille
Magali Vial, Infirmière IDE, CHU Bordeaux
s
thi
uC
Rue d
COMITÉ SCIENTIFIQUE
Julien POOR, Service d’angiographie, Clinique Louis Pasteur, Essey-Les-Nancy
Florian ROBERT, Service d’angiographie, Clinique Louis Pasteur, Essey-Les-Nancy
Muriel ZAGO, Cadre du bloc opératoire, CHU Bordeaux
Ma
Bd Gambetta
ie
Vo
s
Rez de chaussée
R
re
ud
Fau
uta
élix
é Lia
r
Av. F
d
An
nel
Tun
Opéra
de Nice
OLD CITY
Promenade des Anglais
Musée des
Beaux-Arts
de Nice
Adagio Access LES BAUMETTES
Nice Magnan
nie
10 min walking
for
is
ali
C
gla
a
An
el
es
d
d
.
Av
de
na
me
Pro
Centre Universitaire
CUEFLE
s
hi
at
FABRON
e
i
Vo
M
10.00 Café d’accueil sur le hall d’exposition
10.30 • Le point sur les dernières recommandations de revascularisation, TBD
10.45• La radioprotection en salle de cathétérisme, Robert Valette
11.15• L’utilisation d’un amplificateur mobile dans une salle conventionnelle lors de la prise en
charge d’endoprothèses vasculaires : comment adapter la radioprotection au bloc
opératoire ? Michaela Dupont
10
11.30• Acquisition 3D et fusion en salle hybride pour les revascularisations périphériques,
Fabienne Lamniai, Sophie Pichon
11.50 • Discussion
12.10• Les ballons d’angioplasties périphériques, Marie Etlinger
12.25• Drug Eluting Devices-aspects spécifiques, Karine Malo, Magali Vial
12.40• Discussion
13.00 Déjeuner sur le toit terrasse
14.00• La thrombolyse artérielle in situ le point sur les bonnes pratiques, Florian Robert
14.15• Les moyens de protection cérébrale en angioplastie carotide percutanée, Max Amor
14.30• Les abords artériels non conventionnels en angioplastie périphérique, Julien Poor
14.45• Préparation du matériel endovasculaire/anticipation nécessaire, Karine Malo, Magali Vial
15.00• Points de ponctions artériels/anticipation de la préparation et installation du patient,
Karine Malo, Magali Vial
15.15• Complications hémorragiques et complications des points de ponction, Karine Malo,
Magali Vial
15.30• Discussion
16.00 Pause sur le hall d’exposition et fin des sessions
Radisson
BLU Hotel
To the airport
(10 min by car)
11
MEETING VENUE
ORGANIZATION
Radisson BLU Hotel
Registrations &
information desk
Monday June 8 . . . . . . . . . . . 07.30 - 18.30
Tuesday June 9 . . . . . . . . . . . . 07.45 - 18.00
General organization
Vérane Bergeron Moreau
(Executive manager)
+33 621 78 87 16
[email protected]
MEET official dinner
Monday June 8
20.00 till midnight
Radisson BLU Hotel
Private Beach
Participation fee:
60€ VAT incl. per person
(buffet dinner)
Music Entertainment
Dress code: casual but chic
Registration & accommodation
Michèle Caboste
[email protected]
Faculty & marketing coordination
Christine Arzouyan
+33 613 96 08 70
[email protected]
17, rue Venture 13001 Marseille France
Tel. +33 491 57 19 60
Fax +33 491 57 19 61
[email protected]
www.divine-id.com
ABSTRACTS BOOK
2015
Valiant Captivia
Find all abstracts received from
the congress presentations on
www.meetcongress.com
ENDOPROTHÈSE THORACIQUE
SYSTÈME DE POSE
Plus de
67 000
NOUVEAU COMPOSANT PROXIMAL DEGRESSIF (4 MM) FREEFLO
* Avec Valiant dans le monde depuis 9 ans / Product Detail Report - février 2015.
Valiant Captivia est un dispositif de classe III, fabriqué par Medtronic, Inc. - CE n°0086.
Il est destiné au traitement des pathologies de l’aorte thoracique descendante, y compris, sans toutefois s’y limiter,
les anévrysmes et les dissections. L’endoprothèse thoracique Valiant est indiquée pour l’exclusion de l’anévrysme, la
fausse lumière ou le site de rupture et de restauration de la circulation sanguine par la lumière de l’endoprothèse.
Le dispositif est destiné à une utilisation chez les patients candidats à une intervention chirurgicale conventionnelle
et chez ceux qui ne sont pas candidats à une telle intervention en raison de facteurs de risque pré-existants.
Valiant Captivia est inscrit sur la LPPR : 3188576, 3154034, 3177466, 3149197, 3123192, 3142255, 3111591.
Lire attentivement la notice avant toute utilisation.
Medtronic France S.A.S.
27 Quai Alphonse Le Gallo - CS 30001
92513 Boulogne-Billancourt Cedex
www.medtronic.fr
Tél. : 01 55 38 17 00
Fax : 01 55 38 18 00
UC201506637FF © Medtronic, France 2015. Créé en avril 2015. Tous droits réservés. Crédit photos Medtronic, plc.
patients traités*
RCS Nanterre 722 008 232
S.M.A.R.T.® Flex Vascular Stent System
UC201506637FF Com CACVS Valiant Captivia 105x148,5 mm cor1.indd 1
04/05/2
Ranger
TM
Paclitaxel-Coated PTA Balloon Catheter
Our inspiration
came right from
the source.
Experience the latest innovation
in self-expanding stents.
Consistent
& Predictable
Drug Treatment
S.M.A.R.T.® Flex Vascular Stent System
Feeling is believing.
Sterling Balloon Technology
TM
Important Information: Prior to use, refer to the “Instructions for Use” supplied with these devices for indications, contraindications, side effects,
suggested procedure, warnings, and precautions. As part of the Cordis policy of continuous product development, we reserve the right to change
product specifications without prior notification. For healthcare professionals only.
© Johnson & Johnson Medical NV/SA 2014 – December 2014 • Tel: +32 2 746 30 00 • Fax: +32 2 746 34 05
All cited trademarks are the property of their respective owners. CAUTION: The law restricts these devices to sales by or on the order of a physician. Indications, contraindications,
warnings and instructions for use can be found in the product labeling supplied with each device. Information for the use only in countries with applicable health authority product registrations.
Ranger ™ Paclitaxel-Coated PTA Balloon Catheter is owned by Hemoteq AG.
PI-189302-AA OCT2013 © 2015 Boston Scientific Corporation or its affiliates. All rights reserved.
www.bostonscientific.eu
LUNCH
Exhibition Hall
Office
Cloakroom
Toilets
Lifts
1
LEVEL -1
2
Registration desk
AUDITORIUM
Stairs
BUFFET
Storage room
10
BUFFET
3
ePosters
BUFFET
Preview
9
8
7
6
4
5
Booth
Industrial
Booth
Industrial
Booth
Industrial
1
Abbott Vascular
5
Endologix
9
Penumbra
2
Cordis
6
Bard
10
3
Boston Scientific
7
Bentley Innomed
4
Medtronic
8
Spectranetics
Gore
Exhibition hours
Monday: 08.00 - 18.30
Tuesday: 07.45 - 16.00
Acknowledgements
Innovation that Empowers
Partner 2015
15
VASCULAR
Organization
General organization
Vérane Bergeron Moreau
(Executive manager)
+33 (0) 491 57 19 61
+ 33 (0) 621 78 87 16
[email protected]
Système d’endoprothèse périphérique
Excellents Résultats
Cliniques à 3 ans
Registration & accommodation
Michèle Caboste
+33 (0) 491 57 19 60
[email protected]
Faculty & marketing coordination
Christine Arzouyan
+33 (0) 491 57 19 63
+33 (0) 613 96 08 70
[email protected]
Fracture à
1 an dans toutes
les analyses1,2
Absence de
revascularisation de
la lésion cible dans
SUPERB à 3 ans4
lorsque déployé
nominalement4*
lorsque déployé
3*
de perméabilité primaire nominalement
(K-M) dans SUPERB
à 12 mois3
Patients étudiés dans l’étude SUPERB2
Patients “real-world” analysés mondialement dans 7 méta-analyses rétrospectives1
Changer les
Normes
• Imite le mouvement naturel du vaisseau1
• Offre la plus haute résistance à la compression
et une grande flexibilité2
• Bénéfice clinique prouvé3
patients analysés rétrospectivement,
17, rue Venture 13001 Marseille France
Tel +33 (0) 491 57 19 60
Fax +33 (0) 491 57 19 61
[email protected]
www.divine-id.com
Données disponibles chez Abbott Vascular.
* Quand déployé à +/- 10% de la longueur nominale.
SUPERB est une étude sponsorisée par Abbott Vascular (IDEV) et demandée par la FDA.
Endoprothèses périphériques SUPERA; dispositifs médicaux de classe llb. Organisme notifié CE0086, Supera est fabriqué par Abbott Vascular. Mandataire Européen Abbott Vascular International
BVBA. Se référer aux informations de la notice d’instructions qui décrivent les informations de bon usage du dispositif. Veuillez lire attentivement les instructions figurant dans la notice. SUPERA est
pris en charge par l’assurance maladie.
Pour plus d’information, visitez notre site web www.abbott.fr.
Les informations contenues dans ce document sont destinées à la distribution en France uniquement. Ne pas reproduire ou modifier.
Photos prises et conservées par Abbott Vascular.
Toutes les illustrations sont des rendus d’artistes.
©2015 Abbott Vascular. Tous droits réservés. 2-FR-2-4982-03 04-2015